Biocytogen (HKEX: 02315) is excited to attend the Antibody Engineering & Therapeutics US (AET-US) 2024 conference at the Marriott Marquis in San Diego, CA, from December 16-18.
Our Business Development and Licensing Team looks forward to meeting you in person at Booth #212! We will also showcase a poster highlighting Biocytogen’s groundbreaking advancements in the fully human antibody discovery platform. We warmly invite you to schedule a 1-on-1 meeting with us!
Exhibition Session
Poster Session
Poster #22: RenMice Platform: Driving Innovation in Fully Human Antibody Drug Development Across Therapeutic Areas
We look forward to discussing licensing opportunities for new antibody molecules and antibody discovery platforms with you.
Please click here to schedule a 1-on-1 meeting with our BDL team to learn more.